A previously unreported case of suppurative thrombophlebitis due to Clavispora lusitaniae

IF 2.2 4区医学 Q3 MYCOLOGY

Journal de mycologie medicale Pub Date : 2023-08-01 DOI:10.1016/j.mycmed.2023.101390

Toru Yoneda, Takayuki Hoshina, Tomofumi Fukuda, Nao Ohama, Saori Murakawa, Koichi Kusuhara

引用次数: 1

Abstract

We report a case with Clavispora lusitaniae-induced purulent thrombophlebitis. The patient had multiple risk factors for the development of fungal thrombophlebitis including surgical procedure, mechanical ventilation, admission to intensive care unit, total parenteral nutrition and long-term antimicrobial therapy in addition to the insertion of central venous catheter. The symptoms finally improved by a combination therapy of micafungin and flucytosine, but the therapy did not rapidly resolve candidemia. The appropriate antifungal therapy for C. lusitaniae-induced purulent thrombophlebitis is uncertain. Further study is desired to seek the appropriate therapy for the disease.

查看原文本刊更多论文

一例以前未报道的化脓性血栓性静脉炎，原因是卢氏裂孔虫

我们报告了一例鲁西塔尼亚粘孢子虫引起的化脓性血栓性静脉炎。患者有多种发展为真菌性血栓性静脉炎的风险因素，包括手术、机械通气、进入重症监护室、全胃肠外营养和长期抗菌治疗，以及插入中心静脉导管。米卡芬净和氟胞嘧啶的联合治疗最终改善了症状，但该疗法并没有迅速解决念珠菌血症。卢西塔菌引起的化脓性血栓性静脉炎的适当抗真菌治疗尚不确定。需要进一步的研究来寻求合适的治疗方法。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal de mycologie medicale 医学-真菌学

CiteScore

5.10

自引率

2.80%

发文量

审稿时长

6-12 weeks

期刊介绍： The Journal de Mycologie Medicale / Journal of Medical Mycology (JMM) publishes in English works dealing with human and animal mycology. The subjects treated are focused in particular on clinical, diagnostic, epidemiological, immunological, medical, pathological, preventive or therapeutic aspects of mycoses. Also covered are basic aspects linked primarily with morphology (electronic and photonic microscopy), physiology, biochemistry, cellular and molecular biology, immunochemistry, genetics, taxonomy or phylogeny of pathogenic or opportunistic fungi and actinomycetes in humans or animals. Studies of natural products showing inhibitory activity against pathogenic fungi cannot be considered without chemical characterization and identification of the compounds responsible for the inhibitory activity. JMM publishes (guest) editorials, original articles, reviews (and minireviews), case reports, technical notes, letters to the editor and information. Only clinical cases with real originality (new species, new clinical present action, new geographical localization, etc.), and fully documented (identification methods, results, etc.), will be considered. Under no circumstances does the journal guarantee publication before the editorial board makes its final decision. The journal is indexed in the main international databases and is accessible worldwide through the ScienceDirect and ClinicalKey platforms.